KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Return on Sales: 2018-2025

Historic Return on Sales for Amneal Pharmaceuticals (AMRX) over the last 8 years, with Sep 2025 value amounting to 0.02%.

  • Amneal Pharmaceuticals' Return on Sales rose 7.00% to 0.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02%, marking a year-over-year increase of 7.00%. This contributed to the annual value of -0.03% for FY2024, which is 1.00% down from last year.
  • Amneal Pharmaceuticals' Return on Sales amounted to 0.02% in Q3 2025, which was up 9.31% from 0.02% recorded in Q2 2025.
  • In the past 5 years, Amneal Pharmaceuticals' Return on Sales registered a high of 0.02% during Q3 2025, and its lowest value of -0.13% during Q2 2022.
  • Moreover, its 3-year median value for Return on Sales was -0.02% (2023), whereas its average is -0.02%.
  • As far as peak fluctuations go, Amneal Pharmaceuticals' Return on Sales grew by 20bps in 2021, and later dropped by 14bps in 2022.
  • Over the past 5 years, Amneal Pharmaceuticals' Return on Sales (Quarterly) stood at 0.01% in 2021, then declined by 12bps to -0.12% in 2022, then climbed by 9bps to -0.02% in 2023, then fell by 1bps to -0.03% in 2024, then rose by 7bps to 0.02% in 2025.
  • Its Return on Sales stands at 0.02% for Q3 2025, versus 0.02% for Q2 2025 and 0.01% for Q1 2025.